久久亚洲国产成人影院-久久亚洲国产的中文-久久亚洲国产高清-久久亚洲国产精品-亚洲图片偷拍自拍-亚洲图色视频

Global EditionASIA 中文雙語(yǔ)Fran?ais
World
Home / World / Europe

EU backs AstraZeneca COVID-19 vaccine as blood clot reviews continue

Updated: 2021-04-24 05:47
Share
Share - WeChat
[Photo/Agencies]

April 23 - Europe's drug regulator reiterated on Friday the benefits of AstraZeneca's COVID-19 vaccine outweigh any risks, delivering an assessment based on continuing reviews into rare blood clots to help countries determine the shot's use.

The renewed backing comes after several countries in the European Union and worldwide have limited the use of the vaccine, known as Vaxzevria. Denmark has stopped its use altogether, after possible links to clotting issues in combination with low platelet levels were confirmed.

The interim analysis by a committee of the European Medicines Agency (EMA) determined that serious side effects of rare blood clots are likely to occur in 1 out of 100,000 vaccinated people, the regulator said in a statement.

EMA officials said in a briefing the update on Friday was aimed at putting into context the data it has collected and analysed to help 27 EU member states work out how to use the shot based on their local situations.

The advantages of getting the vaccine increase with age and with any rise in infections rates, but the benefits were for now evident across all scenarios and ages, the officials said.

They said the recommendation may be subject to change because more data is being collected, and for instance not all EU member states had included the sex of the vaccine recipients in their data.

But Peter Arlett, head of EMA's data analytics and methods task force, said: "The benefit risk balance of the AstraZeneca vaccine is positive. It's preventing serious disease and saving lives."

Earlier this month, the EMA said it had found a possible link between AstraZeneca's coronavirus vaccine and a similar, rare blood clotting problem connected to the one from Johnson & Johnson which led to a small number of deaths.

There was not enough data on Vaxzevria from Europe to determine if blood clot risks with low blood platelets would differ with each dose of the vaccine, or to provide context on its benefits and risks with regards to gender, the EMA said.

Countries are also in the midst of determining whether to use J&J's vaccine over concerns about blood clots and U.S. regulators were meeting on Friday to consider whether it is safe to resume J&J injections.

Regulators have found these events occurred mostly in the brain and abdomen.

(Reporting by Pushkala Aripaka in Bengaluru, Ludwig Burger in Frankfurt, Alistair Smout and Keith Weir in London; Writing by Josephine Mason; Editing by Saumyadeb Chakrabarty and Sriraj Kalluvila, William Maclean)

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 日韩加勒比在线 | 亚洲精品手机在线观看 | 中文在线三级中文字幕 | 全黄性高视频 | 国产一级一级片 | 日韩三级一区 | 黄页网站18以下禁止观看 | 欧美三级网| 贵州美女一级纯黄大片 | 国产精品三级国语在线看 | 国产精品大全 | 亚洲欧美日韩精品久久 | 看一级毛片一区二区三区免费 | 国产成人久久久精品毛片 | 欧美成人日韩 | 午夜大片免费男女爽爽影院久久 | 国产极品喷水视频jk制服 | 337p欧美| 久久在线国产 | 欧美午夜三级我不卡在线观看 | 日本一本久| 美女被免费视频的网站 | 成人a视频片在线观看免费 成人a视频在线观看 | 国产免费影院 | 成人在线91 | 亚洲大片 | 国内自拍视频在线播放 | 久草草视频在线观看免费高清 | 生活片毛片 | 欧美日韩一区二区三区四区在线观看 | 男人性天堂| 国产日韩美国成人 | 午夜性福 | 美女擦逼| 91免费国产精品 | 日韩色在线 | 亚洲国产欧美91 | 99在线观看视频免费 | 国产精品二区在线 | 久久精品国产欧美日韩99热 | 国产高清一区二区三区免费视频 |